Preservation of nanostructured lipid carriers (NLC)

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 76, Issue 1, 2010, Pages 56-67

  Obeidat, Wasfy M ^a   Schwabe, Kay ^b   Müller, Rainer H ^b   Keck, Cornelia M ^c,d  

^a UNIVERSITY OF SHARJAH   (United Arab Emirates)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^d UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Nanostructured lipid carriers; NLC; Physical stability; Preservative; Zeta potential

Indexed keywords

LIPID; NANOMATERIAL; NANOPARTICLE; PRESERVATIVE; UBIDECARENONE;

ARTICLE; CLASSIFICATION; COST BENEFIT ANALYSIS; DISPERSION; LIGHT; MICROSCOPY; SCREENING;

EID: 77955664124     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.05.001     Document Type: Article

References (41)

1. Müller R.H., Radtke M., Wissing S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 2002, 242(1-2):121-128.
2. Muchow M., Maincent P., Müller R.H. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev. Ind. Pharm. 2008, 34(12):1394-1405.
3. Cavalli R., Gasco M.R., Chetoni P., Burgalassi S., Saettone M.F. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int. J. Pharm. 2002, 238(1-2):241-245.
4. Joshi M.D., Müller R.H. Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm. 2009, 71(2):161-172.
5. Müller R.H., Petersen R.D., Hommoss A., Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug Deliv. Rev. 2007, 59(6):522-530.
6. Pardeike J., Hommoss A., Müller R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 2009, 366(1-2):170-184.
7. Wissing S.A., Müller R.H. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity - in vivo study. Eur. J. Pharm. Biopharm. 2003, 56(1):67-72.
8. Keck C.M., Schwabe K. Silver-nanolipid complex for application to atopic dermatitis skin: rheological characterization, in vivo efficiency and theory of action. J. Biomed. Nanotechnol. 2009, 5(4):428-436.
9. Santos Maia C., Mehnert W., Schaller M., Korting H.C., Gysler A., Haberland A., Schäfer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target. 2002, 10(6):489-495.
10. J. Pardeike, R.H. Müller, Coenzyme Q10-loaded NLCs: preparation, occlusive properties and penetration enhancement, Pharm. Technol. Eur. (01), July 2007 (online journal).
11. J. Pardeike, K.H. Schulz, T. Miller, R.H. Müller, Coenzyme Q10 loaded NLC: in vitro release and in vivo skin penetration, in: AAPS Annual Meeting & Exposition, San Diego, CA, 2007.
12. R.H. Müller, C.M. Keck, Nanostructured lipid carriers (NLC) for the use in pharma, cosmetics, food and agri. particles, Orlando, 2004.
13. Porter C.J.H., Wasan K.M., Constantinides P. Lipid-based systems for the enhanced delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 2008, 60(6):615-778.
14. J.S. Lucks, R.H. Müller, Medication vehicles made of solid lipid particle (solid lipid Nanospheres-SLN), European Patent EP19920919477 1992, MEDAC GmbH.
15. R.H. Müller, V. Jenning, K. Mäder, A. Lippacher, Lipid particles on the basis of mixtures of liquid and solid lipids and the method for producing same, PCT/EP2000/004112, European Patent Application EP1176949, PharmaSol GmbH, 2000.
16. Lippacher A., Müller R.H., Mäder K. Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties. Eur. J. Pharm. Biopharm. 2002, 53(2):155-160.
17. Westesen K., Siekmann B. Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int. J. Pharm. 1997, 151:35-45.
18. Freitas C., Müller R.H. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 1999, 47(2):125-132.
19. K.H. Bauer, K.-H. Frömming, C. Führer, Lehrbuch der Pharmazeutischen Technologie, Wissenschaftliche Verlagsgesellschaft mbH, Suttgart, 2002.
20. R. Voigt, Pharmazeutische Technologie, Deutscher Apotheker Verlag, Stuttgart, 2006.
21. Kosmetik-Verordnung in der Fassung der Bekanntmachung vom 7, Oktober 1997 (BGBl. I S.2410), die zuletzt durch die Verordnung vom 3, Februar 2010 (BGBl. I S. 65) geändert worden ist.
22. W. Umbach, Kosmetik und Hygiene: von Kopf bis Fuß, Wiley VHC, Weinheim, 2004.
23. Mekos Laboratories, PRODUCT INFORMATION - Allergen Patch Test T.R.U.E. TEST, 2007.
24. Schülke & Mayr GmbH, Euxyl® PE 9010, Product information, Preservatives for cosmetics http://www.schuelke-mayr.com.
25. A.G. Symrise, Hydrolite® 5 - product information, Active Ingredients http://www.symrise.com.
26. Mehnert W., Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 2001, 47(2-3):165-196.
27. Liedtke S., Wissing S., Muller R.H., Mader K. Influence of high pressure homogenisation equipment on nanodispersions characteristics. Int. J. Pharm. 2000, 196(2):183-185.
28. R.H. Müller, R. Schuhmann, Teilchengrößenmessung in der Laborpraxis, Band 38, in: A. Paperback (ed.), Wissenschaftliche Verlagsgesellschaft mbH, Suttgart, 1996.
29. Malvern, Dynamic Light Scattering: An Introduction in 30 min, DLS technical note: MRK 656-01.
30. International Organisation for Standardisation (ISO), International Standard ISO13321: Methods for Determination of Particle Size Distribution Part 8: Photon Correlation Spectroscopy, 1996.
31. A. Rawle, Basic Principles of Particle Size Analysis, Technical Paper Malvern Instruments.
32. C. Keck, R.H. Müller, Particle Size Analysis with Laser Diffractometry is not Sensitive Enough to Detect Changes in a Lipid Carrier System, AAPS, Nashville, 2005.
33. Keck C.M., Müller R.H. Size analysis of submicron particles by laser diffractometry - 90% of the published measurements are false. Int. J. Pharm. 2008, 355(1-2):150-163.
34. C.M. Keck, Cyclosporine nanosuspensions: optimised size characterisation & oral formulations, PhD thesis, 2006.
35. Müller R.H., Heinemann S. Photon correlation spectroscopy and zeta potential characterization of model particles and colloidal drug carriers - essential information for the interpretation of cell culture studies. Biochem. Soc. Trans. 1991, 19(2):502.
36. R.H. Müller, Zetapotential und Partikeladung in der Laborpraxis, Band 37, in: A. Paperback (ed.), Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1996.
37. Malvern, Zeta Potential: An Introduction in 30 min, in: Application Note , MRK654 01. http://www.malvern.co.uk.
38. Riddick T.M. Control of Colloid Stability through Zeta Potential 1968, Zeta-Meter Inc. via Livingston Publishing Company, Wynnewood.
39. L. Al Shaal, R.H. Müller, C.M. Keck, Production & stability of dermal hesperetin nanosuspensions, in: 5th German-Polish Symposium, New Challenges for Pharmaceutical Sciences, Poznan/Poland, 2009, P05.
40. Schülke & Mayr GmbH, Euxyl K700 product description.
41. Tadros T.F. Applied Surfactants - Principles and Applications 2005, Wiley VHC, Weinheim.